InspireMD Inc Forecast, price target & analysts
$2.19
3.10%
yesterday
Nasdaq,
May 20, 09:50 pm CET
InspireMD Inc Target price 2025 - Analyst rating & recommendation
Powered by
InspireMD Inc Classifications & Recommendation:
Buy
100%
InspireMD Inc Price Target
| Target Price | $4.50 |
| Price | $2.19 |
| Potential |
105.48%
register free of charge
|
| Number of Estimates | 2 |
|
2 Analysts have issued a price target InspireMD Inc 2026 .
The average InspireMD Inc target price is $4.50.
This is
105.48%
register free of charge
$5.00
128.31%
register free of charge
$4.00
82.65%
register free of charge
|
|
| A rating was issued by 2 analysts: 2 Analysts recommend InspireMD Inc to buy, 0 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the InspireMD Inc stock has an average upside potential 2026 of
105.48%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
Create a premium account to unlock analyst estimates.
Learn more
Powered by
Quarter
Annually
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 7.01 | 7.21 |
| 12.88% | 2.80% | |
| EBITDA Margin | -473.89% | -639.96% |
| 40.74% | 36.23% |
2 Analysts have issued a sales forecast InspireMD Inc 2025 . The average InspireMD Inc sales estimate is
$7.2m
Unlock
2.51%
higher
Unlock
$8.0m
13.98%
Unlock
$6.4m
8.96%
Unlock
This results in the following potential growth metrics:
2 Analysts have issued an InspireMD Inc EBITDA forecast 2025. The average InspireMD Inc EBITDA estimate is
$-46.1m
Unlock
23.84%
lower
Unlock
$-44.8m
20.30%
Unlock
$-47.4m
27.38%
Unlock
This results in the following potential growth metrics and future EBITDA Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
Create a premium account to unlock analyst estimates.
Learn more
Powered by
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| EV/Sales | 6.01 |
Current InspireMD Inc Upgrades & Downgrades
Create a Premium account to unlock Upgrades/Downgrades.
Learn more
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Piper Sandler |
Locked
➜
Locked
|
Locked | May 12 2025 |
| Lake Street |
Locked
➜
Locked
|
Locked | Dec 11 2024 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Sep 17 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Piper Sandler:
Locked
➜
Locked
|
May 12 2025 |
|
Locked
Lake Street:
Locked
➜
Locked
|
Dec 11 2024 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Sep 17 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
